Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Acquisition

1 Jul 2005 07:00

Cello Group plc01 July 2005 CELLO ACQUIRES LEAPFROG RESEARCH AND PLANNING Cello Group plc ("Cello"), the marketing services group which listed on AIM inNovember 2004, has acquired Leapfrog Research & Planning Limited ("Leapfrog"), aleading consumer market research and planning shop, for a total maximumconsideration of £6 million in cash, loan notes and new ordinary shares. Leapfrog, which was established in 1994 by Judy Taylor and Andrea Berlowitz,acts for a number of blue chip clients including Tesco, GSK, BBC, ScottishCourage, AA, RHM and Wyeth. The initial consideration consists of up to £3 million. £2.9 million will bepaid on completion, of which £1.74 million is payable in cash and the balancesatisfied by the issue of 1,007,819 new ordinary shares. In addition, there isa further payment of up to £0.1 million, payable 40% in loan notes and 60% innew ordinary shares, after 12 months and a maximum final consideration of up toa further £3 million dependent on the financial performance of Leapfrog for theperiod to 31 December 2009. The final consideration is payable in a mixture ofloan notes and new ordinary shares at Cello's discretion, with a maximum shareelement of 75%. For the year to 30 April 2005, Leapfrog had a turnover of £3.32 million, grossprofits of £2.28 million and profits before tax of £0.275 million. Application has been made to the London Stock Exchange for the new shares to beadmitted to AIM and it is expected that admission will take place by 6 July2005. Kevin Steeds, Cello Chairman, said: "Leapfrog is an exciting addition to the Cello Group, bringing to us first classconsumer market research and brand planning capabilities which are highlyrespected in the industry. It has a powerful synergy with Insight, oursuccessful international healthcare research and planning business. "Leapfrog is the first of a number of developments which will strengthen ourspecialist research, brand and direct marketing platforms. We expect toannounce further earnings enhancing acquisitions shortly." 1 July 2005 Enquiries: Cello GroupKevin Steeds, Executive Chairman 020 7457 2020 College HillAdrian Duffield/Clare Warren 020 7457 2020 Notes to Editors (www.cellogroup.co.uk) Cello Group plc, a marketing services group which listed on AIM in November 2004is based on three platforms, each operating within a different niche of themarketing services sector: market research, brand development and directmarketing & database management. Following the completion of the acquisition of Leapfrog, Cello will haveannualised turnover of approx £50 million, gross profits of approx £25 millionand employ over 300 people. Each platform share significant organic and acquisitive growth potential; bluechip client lists and a long track record of client loyalty; experienced, highquality management teams; profitability; and potential for enhancing grossmargins. Market Research • Insight Research Group - London and New York Insight is a specialist healthcare market research business which offers a broadrange of quantitative and qualitative research solutions. Its clients includeGlaxoSmithKline, Novartis, AstraZeneca, Shire Pharmaceuticals, NovoNordisk,Boehringer Ingleheim, Lundbeck, Pfizer, Roche and Merck, Sharp and Dohme. Brand Development • Leith - Edinburgh and London The largest and most successful advertising agency in Scotland. The agency hasbeen voted Scottish Agency of the Year for the last five years. Leith opened aLondon office in 2000 to bring its successful combination of creativity andpragmatism to a wider audience. Leith's major clients include Standard Life,Irn Bru, Scottish Executive, Standard Life Bank, Hotpoint, Goodfellas Pizza andCarling. Direct Marketing & Data Base Management • Target Group - Cheltenham and Cirencester The UK's leading direct and database marketing consultancy specialising in the "not-for-profit" and charity sector. The agency works for five of the top 20charities in the UK. In 2003 Target won two IPA Advertising EffectivenessAwards. Recently Target has begun to expand into the "grey sector" of productsand services for older people for clients such as National Trust, Saga andWhich? Limited. • Navigator Responsive Advertising - Edinburgh Navigator Responsive Advertising, Scotland's leading direct marketing agencyprovides responsive communication solutions for a wide range of clientsincluding HBOS Group, De Vere Resort Ownership, ScottishPower, Scottish Widows,Intelligent Finance and Remy Martin. Navigator's specialisms complementTarget's not-for-profit focus with expertise in the commercial market. Thisbusiness has been incorporated into the Target platform. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th May 20137:00 amRNSBoard Appointment
14th May 20137:00 amRNSAGM STATEMENT
10th May 20132:28 pmRNSAdditional Listing/TVR
23rd Apr 20137:00 amRNSHolding(s) in Company
19th Apr 20137:00 amRNSFace Launches Pulsar TRAC
12th Apr 20131:03 pmRNSAnnual Report and Accounts 2012
9th Apr 20137:00 amRNSDirector/PDMR Shareholding
2nd Apr 201312:44 pmRNSHolding(s) in Company
27th Mar 201310:00 amRNSHolding(s) in Company
20th Mar 20137:00 amRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSPreliminary Results for the Year Ended 31 Dec 2012
1st Mar 20137:00 amRNSTotal Voting Rights
28th Jan 20137:00 amRNSPre-close trading update
28th Jan 20137:00 amRNSAcquisition of Mash Health
19th Dec 20129:50 amRNSHolding(s) in Company
14th Nov 20127:00 amRNSHealthcare Seminar
1st Oct 201212:29 pmRNSShare Option Grants
20th Sep 20129:09 amRNSDirector/PDMR Shareholding
19th Sep 20122:13 pmRNSDividend Timetable
19th Sep 20127:01 amRNSCello's Talking Taboos
19th Sep 20127:00 amRNSInterim Results 2012
3rd Sep 20128:30 amRNSNotice of Interim results
12th Jul 20122:21 pmRNSShare Option Grants
11th Jul 20127:00 amRNSTrading update
1st Jun 20127:00 amRNSTotal Voting Rights
24th May 20127:00 amRNSAdditional listing / TVR
16th May 201210:07 amRNSResult of AGM
15th May 20127:00 amRNSAGM Statement
1st May 20127:00 amRNSAdditional Listing
17th Apr 20127:00 amRNSAnnual Financial Report
27th Mar 20127:00 amRNSHolding(s) in Company
14th Mar 20127:00 amRNSDirector/PDMR Shareholding
13th Mar 20127:00 amRNSLaunch of CSR programme
13th Mar 20127:00 amRNSFinal Results
24th Jan 201212:59 pmRNSNotice of Results
23rd Jan 20127:01 amRNSYear end trading update
21st Dec 20117:00 amRNSDirectorate Change
19th Dec 20117:00 amRNSChange of Adviser
1st Nov 201111:30 amRNSHolding in Company
18th Oct 20117:00 amRNSHolding in Company
4th Oct 20117:00 amRNSDirector/PDMR Shareholding
21st Sep 201110:30 amRNSDirector/PDMR Shareholding
10th Aug 201110:37 amRNSNotice of Results
13th Jul 20117:00 amRNSDirector/PDMR Shareholding
6th Jul 20117:00 amRNSTrading update
14th Jun 20117:00 amRNSShare Option Grants
3rd Jun 201110:10 amRNSTotal Voting Rights
26th May 20117:00 amRNSAnalyst and investor teach-in
17th May 20111:23 pmRNSResult of AGM
17th May 20117:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.